Dr Vivien Li
Clinical (Fellow)
Department of Medicine
6 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Identification of an immunogenic epitope from RASGRP2 with specificity for HLA-DR15 in multiple sclerosis
DOI: 10.1016/j.jneuroim.2026.5789712025
Journal article
A single nucleotide polymorphism in the MerTK gene is associated with increased radiological disease activity in patients with multiple sclerosis on natalizumab therapy
DOI: 10.1016/j.msard.2025.1066352024
Journal article
Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis
DOI: 10.1016/j.jneuroim.2024.5783472023
Journal article
HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS
DOI: 10.1212/NXI.00000000002001902023
Journal article
The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK
DOI: 10.3390/ijms2421159032023
Research grants (other domestic)
Advancing Tolerogenic Therapy for MS
2020
Research grants (ARC, NHMRC, MRFF)
Towards Developing Dendritic Cell Therapy for MS Based on Promoting Mertk Signalling
RECENT SCHOLARLY WORKS
2022
Journal article
Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic
DOI: 10.1016/j.msard.2022.103913